CARDIOVASCULAR
hamburger
product photo
EXCELLENT RESULTS ACROSS THE WIDEST RANGE OF APPLICATIONS

The CentriMag™ Circulatory Support System with Full MagLev™ flow technology offers excellent hemocompatibility and unparalleled versatility for optimized patient care.

FULL MAGLEV™ FLOW TECHNOLOGY: DESIGNED FOR OPTIMAL HEMOCOMPATIBILITY1,2

Driven by Full MagLev flow technology, the CentriMag pump includes a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.3,4

play video
MAGLEV™ FLOW TECHNOLOGY

Watch this video to see the CentriMag™ pump’s Full MagLev™ flow technology in action, with electromagnetic forces controlling a levitated rotor for precise control of rotational speed.

ADDRESSING THE BROADEST SPECTRUM OF CLINICAL CHALLENGES

The CentriMag Circulatory Support System helps you provide optimal patient care by addressing a breadth of clinical needs and applications. The CentriMag Circulatory Support System is used as part of a cardiopulmonary or extracorporeal bypass circuit for periods up to 6 hours to support the left, right or both ventricles of the heart.

 

diagram of the types of support in Centrimag
TRUSTED FOR A WIDE RANGE OF PATIENT TYPES AND SIZES

The CentriMag Circulatory Support System includes both pediatric and adult pump options, capable of producing flows up to 9.9 LPM.

 

graphic of different sizes of people

DESIGNED TO MEET INDIVIDUALIZED REQUIREMENTS

What You Need

Giving you freedom of choice, the CentriMag system:

  • Fits seamlessly into custom circuit designs to easily adapt to clinician preferences
  • Can be used with a variety of cannulation options
BUILDING COMPREHENSIVE HEART FAILURE MANAGEMENT

The CentriMag Circulatory Support System is part of our heart failure management portfolio. Our vision is to transform the treatment of heart failures by designing technology that improves workflow and efficiency. Read more about our approach to heart failure management.

REFERENCES

*Cleared for six-hour use. 
**Humanitarian Use Device. The CentriMag™ RVAS is authorized by Federal law to provide temporary circulatory support for up to 30 days for patients in cardiogenic shock due to acute right ventricular failure. The effectiveness of this device for this use has not been demonstrated. Distribution of this device is restricted to use by or on the order of a physician. 
1. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085 
2. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939.http://dx.doi.org/10.1016/j.jtcvs.2010.03.046 
3. Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71.http://dx.doi.org/10.1016/j.healun.2009.08.025 
4. Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976.http://dx.doi/org/10.1016/j.healun.2009.04.015

FULL MAGLEV™ FLOW TECHNOLOGY: EASY ON THE BLOOD

Designed for optimal hemocompatibility,1,2 Full MagLev flow technology can result in low hemolysis1 and low device-related thrombosis.1,2

 

graphic displaying five percent low haemolysis
graphic displaying two point five percent low device-related thrombosis
REDUCED BLOOD TRAUMA,3 MINIMIZED TURBULENCE, MAINTAINED STABILITY

Providing a contact-free environment, Full MagLev technology features:

  • free-floating magnetically levitated rotor prevents surface-to-surface contact that could cause blood trauma
  • Wide blood-flow pathways and absence of seals, bearings and valves minimize blood turbulence and stasis
  • Automatic rotor positioning adjusts 50,000 times per second to maintain stable and consistent blood flow

 

graphic displaying the magnetic rotor
REFERENCES

1. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046

2. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, L. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085

3. Zhang, J., Gellman, B., Koert, A., Dasse, K. A., Gilbert, R. J., Griffith, B. P., & Wu, Z. J. (2006). Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artificial Organs, 30(3), 168-177. http://dx.doi.org/10.1111/j.1525-1594.2006.00203.x

CUSTOMER
SERVICE

Our customer service experts can help with your
product orders or questions

a natural wonder of sandstone caves

OUR PRODUCTS

See our featured innovations and technologies, full product catalog and approach to disease state management.

INDICATIONS, SAFETY & WARNINGS

Rx Only

Brief Summary: Caution: U.S. federal law restricts this device to sale by or on the order of a physician.

Humanitarian Device Statement: Caution: Humanitarian Device. The CentriMag™ RVAS is authorized by Federal Law for temporary circulatory support for up to 30 days for patients in cardiogenic shock due to right ventricular failure. The effectiveness of this device for this use has not been demonstrated.

CentriMag™ Blood Pump Indications [510(k) Clearance; 6-hour use]: The Abbott CentriMag Blood Pump is indicated for use only with the Thoratec CentriMag Console to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours). It is also indicated for use in extracorporeal support systems (for periods up to six hours) not requiring complete cardiopulmonary bypass (e.g. valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants etc.).

CentriMag Blood Pump Contraindications [510(k) Clearance; 6-hour use]: The Abbott CentriMag Blood Pump is contraindicated for use as a cardiotomy suction device. It is also contraindicated for patients who are unable or unwilling to be treated with heparin or an appropriate alternative anti-coagulant.

PediMag™ Blood Pump Indications for Use [510(k) Clearance; 6-hour use]: The PediMag Blood Pump is indicated for use with the CentriMag Console to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours) for surgical procedures such as mitral valve reoperation. It is also indicated for use in extracorporeal support systems (for periods up to six hours) not requiring complete cardiopulmonary bypass (e.g. valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants etc.).

PediMag Blood Pump Contraindications [510(k) Clearance; 6-hour use]: The PediMag Blood Pump is contraindicated for use as a cardiotomy suction device. It is also contraindicated for patients who are unable or unwilling to be treated with heparin or an appropriate alternative anti-coagulant.

CentriMag™ Drainage (Venous) Cannula Kit Indications for Use [510(k) Clearance; 6-hour use]: The CentriMag Drainage (Venous) Cannula is indicated for use with an extracorporeal bypass circuit for extracorporeal circulatory support for periods up to six hours.

CentriMag Drainage (Venous) Cannula Kit Contraindications [510(k) Clearance; 6-hour use]: The CentriMag Drainage (Venous) Cannula is contraindicated for patients who are unable or unwilling to be treated with heparin. The CentriMag Drainage (Venous) Cannula is not intended for peripheral cannulation.

CentriMag™ Return (Arterial) Cannula Kit Indications for Use [510(k) Clearance; 6-hour use]: The CentriMag Return (Arterial) Cannula is indicated for use as an arterial return cannula with an extracorporeal bypass circuit for extracorporeal circulatory support for periods up to six hours.

CentriMag Return (Arterial) Cannula Kit Contraindications [510(k) Clearance; 6-hour use]: The CentriMag Return (Arterial) Cannula is contraindicated for patients who are unable or unwilling to be treated with heparin. The CentriMag Return (Arterial) Cannula is not intended for peripheral cannulation.

Please refer to the CentriMag Instructions for Use for additional warnings and precautions.

Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, Abbott or one of its subsidiaries. ABBOTT and the nine-squares symbol are trademarks and service marks of Abbott and its related companies. © 2018 Abbott. All Rights Reserved.

INDICATIONS, SAFETY & WARNINGS

SJM-CV WEB-0718-0035(1)

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?